Table Graph
      published meta-analysis   sensitivity analysis   studies

placebo in COVID-19 mild to moderate - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsLibster, 2020 (REV) 2.00 [0.37; 10.85] 2.00[0.37; 10.85]Libster, 2020 (REV)10%160NAnot evaluable clinical deteriorationdetailed resultsLibster, 2020 (REV) 1.92 [1.07; 3.46] 1.92[1.07; 3.46]Libster, 2020 (REV)10%160NAnot evaluable ICU admissiondetailed resultsLibster, 2020 (REV) 3.03 [0.63; 14.49] 3.03[0.63; 14.49]Libster, 2020 (REV)10%160NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-08-11 20:07 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 90 - treatments: 650 - roots T: 650

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons